Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 212 (RN7SKP212) is a pseudogene related to the 7SK small nuclear RNA gene family. It does not produce a functional RNA and has no identified biological activity. Pseudogenes such as RN7SKP212 result from gene duplication or retrotransposition events and typically lack the regulatory or coding capacity of their parental genes. There is no evidence that RN7SKP212 encodes a protein, participates in any molecular pathways, or is involved in disease processes. It is not a drug target, nor does it serve a diagnostic or therapeutic role. Context: - The parental gene, RN7SK, encodes an abundant and highly conserved small nuclear RNA (snRNA) that serves as a key regulator of RNA polymerase II (RNAPII) transcriptional elongation via modulating the activity of positive transcription elongation factor b (P-TEFb)[1][2][3]. 7SK snRNA functions as part of the 7SK ribonucleoprotein complex; however, there is no functional evidence or therapeutic interest in RN7SK pseudogenes such as RN7SKP212. - The existence of multiple pseudogenes related to small RNA families, such as 7SK, is common in higher eukaryotic genomes[4]. These pseudogenes are cataloged in genome databases but do not have described functional roles. Summary: RN7SKP212 is not a receptor, enzyme, transporter, or recognized therapeutic target. Its inclusion in target lists is likely erroneous unless specifically considering the genomics of pseudogenes rather than functional targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 212 (RN7SKP212).